So why has POH has been so silent lately and not showing any signs of useful product work/announcements.
They've been BUSY interviewing potential new Directors.
So NOW we're paying all these Directors to manage a business that really doesn't have a lot new to offer anyone (versus 1,2,3 years ago) except talk of "potential this & potential that". They need to get on with completing any/all clinical trials and give the market proven reasons to be interested in doing business with POH.
Three new Directors appointed, page-15
Add AVE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.001(20.0%) |
Mkt cap ! $9.507M | |||
| Open | High | Low | Value | Volume |
| 0.3¢ | 0.3¢ | 0.3¢ | $408 | 154.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 61 | 90794613 | 0.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.3¢ | 54998583 | 13 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| AVE (ASX) Chart |